no negative comments jsut facts all bio-techs have come back 50% or more since good news no matter how good a company is you can always pay too much ...nal is a good company but not worth these prices until many many years into the future
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
